107 related articles for article (PubMed ID: 16681582)
1. Pseudoscleroderma associated with cancer.
Kikuchi K; Hoashi T; Yazawa N; Tamaki K
Clin Exp Dermatol; 2006 May; 31(3):381-3. PubMed ID: 16681582
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis.
Lawrence A; Khanna D; Misra R; Aggarwal A
Dermatol Online J; 2006 Jan; 12(1):2. PubMed ID: 16638370
[TBL] [Abstract][Full Text] [Related]
3. [Scleroderma].
Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma histamine levels in systemic sclerosis (scleroderma).
Falanga V; Soter NA; Altman RD; Kerdel FA
Arch Dermatol; 1990 Mar; 126(3):336-8. PubMed ID: 2310207
[TBL] [Abstract][Full Text] [Related]
5. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
6. Salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with oral squamous cell carcinoma.
Vucicević Boras V; Cikes N; Lukać J; Virag M; Cekić-Arambasin A
Minerva Stomatol; 2005 Oct; 54(10):569-73. PubMed ID: 16224376
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Scleroderma: Are There Any Clues?
Jedlickova H; Durčanská V; Vašků V
Acta Dermatovenerol Croat; 2016 Apr; 24(1):78-80. PubMed ID: 27149136
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis.
Mok MY; Cheung BM; Lo Y; Leung RY; Wong WS; Lau CS
J Rheumatol; 2007 Nov; 34(11):2224-9. PubMed ID: 17937467
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
Coelho LF; de Oliveira JG; de Oliveira DB; Guedes AC; Lanna CC; Prados RZ; Ferreira PC; Bonjardim CA; Kroon EG
Arch Dermatol Res; 2007 Aug; 299(5-6):259-62. PubMed ID: 17541615
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of 8 cases of pericarditis in patients with neoplasms].
Gutiérrez M; Tres A; Abós ME; Fuertes MA; Millastre A; Rodrigo G; Peleato A; Arraiza A; Azua J
Rev Esp Oncol; 1981; 28(2):203-26. PubMed ID: 6820826
[No Abstract] [Full Text] [Related]
12. Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity.
Yoshizaki A; Iwata Y; Komura K; Hara T; Ogawa F; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2008 Sep; 35(9):1825-9. PubMed ID: 18688912
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
14. Expression of insulin-like growth factor-I in lesional and non-lesional skin of patients with morphoea.
Fawzi MM; Tawfik SO; Eissa AM; El-Komy MH; Abdel-Halim MR; Shaker OG
Br J Dermatol; 2008 Jul; 159(1):86-90. PubMed ID: 18489607
[TBL] [Abstract][Full Text] [Related]
15. Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of skin scleroderma--literature review].
Wojas-Pelc A; Lipko-Godlewska S
Przegl Lek; 2005; 62(5):310-3. PubMed ID: 16334538
[TBL] [Abstract][Full Text] [Related]
17. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
20. Pruritus, an uncommon but important symptom of systemic carcinoma.
Cormia FE
Arch Dermatol; 1965 Jul; 92(1):36-9. PubMed ID: 11850949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
